Dementia with Lewy bodies. Pure and mixed forms;Demencia con cuerpos de Lewy. Formas puras y mixtas

Revista de Neurologia

Volumn 35, Issue 8, 2002, Pages 761-765

  Del Ser, Teodoro ^a  

^a HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

Alzheimer's disease; Cognitive fluctuations; Dementia with Lewy bodies; Mental deterioration; Parkinsonism

Indexed keywords

CLOZAPINE; DONEPEZIL; LEVODOPA; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE;

ALZHEIMER DISEASE; BASAL GANGLION; BRAIN CORTEX; BRAIN STEM; CLINICAL FEATURE; CONFERENCE PAPER; CONFUSION; DRUG HYPERSENSITIVITY; EXTRAPYRAMIDAL SYMPTOM; HALLUCINATION; LEWY BODY; MENTAL DETERIORATION; PARANOIA; PATHOLOGICAL ANATOMY; PROTEIN LOCALIZATION;

EID: 0037121152     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3508.2002001     Document Type: Conference Paper

References (64)

1. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-24.
2. Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999; 174: 45-50.
3. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990; 237: 197-204.
4. Galasko D, Salmon DP, Thal LJ. The nosological status of Lewy body dementia. In Perry R, McKeith I, Perry E, eds. Dementia with Lewy bodies. Clinical, pathological and treatment issues. Cambridge: Cambridge University Press; 1996. p. 21-32.
5. Hansen LA, Samuel W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 1997; 48: 126-32.
6. Hansen LA, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990; 40: 1-8.
7. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59.
8. Dickson DW, Crystal H, Mattiace LA, Kress Y, Schwagerl A, Ksiezak-Reding H, et al. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol 1989; 78: 572-84.
9. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 1991; 41: 1402-9.
10. Byrne EJ, Lennox G, Lowe J, Godwin-Austen RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989; 52: 709-17.
11. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990; 95: 119-39.
12. Gómez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology 1999; 53: 1284-91.
13. Gómez-Isla T, Growdon WB, McNamara M, Newell K, Gómez-Tortosa E, Hedley-Whyte ET, et al. Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies. Neurology 1999; 53: 2003-9.
14. Gómez-Isla T, Growdon W, McNamara M, Growdon JH, Hyman BT. Diffuse Lewy Body Dementia: Quantitative Neuropathological Studies and APOE Genotyping. Neurology 1997; 48: 140-1.
15. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body Disease: a comparative clinicopathological study. Ann Neurol 1994; 35: 81-8.
16. Armstrong RA, Cairns NJ, Lantos PL. Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: comparison with non-demented cases and Alzheimer's disease. Dement Geriatr Cogn Disord 2000; 11: 187-92.
17. Lippa CF, Johnson R, Smith TW. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease. Ann Neurol 1998; 43: 102-6.
18. Kosaka K. Dementia and neuropathology in Lewy body disease. Adv Neurol 1993; 60: 456-63.
19. Forstl H, Burns A, Luthert P, Cairns N, Levy R. The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry 1993; 162: 385-92.
20. Crystal HA, Dickson DW, Sliwinski MJ, Lipton RB, Grober E, Marks-Nelson H, et al. Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 1993; 34: 566-73.
21. Kachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985; 42: 1097-105.
22. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572-80.
23. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988; 38: 1682-7.
24. Heyman A, Fillenbaum GG, Gearing M, Mirra SS, Welsh-Bohmer KA, Peterson B, et al. Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. Neurology 1999; 52: 1839-44.
25. Gearing M, Lynn M, Mirra SS. Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups. Arch Neurol 1999; 56: 203-8.
26. Brown DF, Risser RC, Bigio EH, Tripp P, Stiegler A, Welch E, et al. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging. J Neuropathol Exp Neurol 1998; 57: 955-60.
27. Lippa CF, Ozawa K, Mann DM, Ishii K, Smith TW, Arawaka S, et al. Deposition of beta-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease. Arch Neurol 1999; 56: 1111-8.
28. Samuel W, Alford M, Hofstetter CR, Hansen L. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol 1997; 56: 499-508.
29. Hansen LA, Masliah E, Galasko D, Terry RD. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993; 52: 648-54.
30. Irizarry MC, Hyman BT, Clayton DF, George JM, Newell K, Gómez-Isla T, et al. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol 1998; 57: 334-7.
31. Mattila PM, Rinne JO, Helenius H, Roytta M. Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology. Acta Neuropathol (Berl) 1999; 98: 157-64.
32. Masliah E, Mallory M, DeTeresa R, Alford M, Hansen L. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies. Brain Res 1993; 671: 258-66.
33. Hansen LA, Daniel SE, Wilcock GK, Love S. Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia. J Neurol Neurosurg Psychiatry 1998; 64: 653-6.
34. Wu E, Lipton RB, Dickson DW. Amyloid angiopathy in diffuse Lewy body disease. Neurology 1992; 42: 2131-5.
35. Martinoli MG, Trojanowski JQ, Schmidt ML, Arnold SE, Fujiwara TM, Lee VM, et al. Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia. Acta Neuropathol Berl 1995; 90: 239-43.
36. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996; 148: 2083-95.
37. Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, et al. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44: 1950-1.
38. Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, et al. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord 1993; 7: 69-79.
39. Del Ser T, Hachinski V, Merskey H, Mufioz DG. Clinical and pathological features of two groups of dementia with Lewy bodies: effect of co-existing Alzheimer-type lesion load. Alz Dis Assoc Disord (In press).
40. Ala TA, Yang KH, Sung JH, Frey WH. Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study. J Neurol Neurosurg Psychiatry 1977; 62: 16-21.
41. Galasko D, Katzman R, Salmon DP, Hansen L. Clinical and neuropathological findings in Lewy body dementias. Brain Cogn 1996; 31: 166-75.
42. Cercy SP, Bylsma FW. Lewy bodies and progressive dementia: a critical review and meta-analysis. J Int Neuropsychol Soc 1997; 3: 179-94.
43. López OL, Hamilton RL, Becker JT, Wisniewski S, Kaufer DI, DeKosky ST. Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology 2000; 54: 1780-7.
44. López OL, Wisniewski S, Hamilton RL, Becker JT, Kaufer DI, DeKosky ST. Predictors of progression in patients with AD and Lewy bodies. Neurology 2000; 54: 1774-9.
45. McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000; 54: 1050-8.
46. Hohl U, Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. Diagnostic accuracy of dementia with Lewy bodies. Arch Neurol 2000; 57: 347-51.
47. Verghese J, Crystal HA, Dickson DW, Lipton RB. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology 1999; 53: 1974-82.
48. López OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, et al. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 1999; 53: 1292-9.
49. Luis CA, Barker WW, Gajaraj K, Harwood D, Petersen R, Kashuba A, et al. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy verified sample. Int J Geriatr Psychiatry 1999; 14: 526-33.
50. Weiner MF, Risser RC, Cullum CM, Honig L, White C III, Speciale S, et al. Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry 1996; 153: 1269-73.
51. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992; 22: 911-22.
52. McKeith IG, Ayre GA, Pincock CP, Wesnes K, Ballard C, Lowery K, et al. The relative impairment of attentional and secondary memory function distinguishes dementia with Lewy bodies and Alzheimer's disease. Neurobiol Aging 1998; 19 (Suppl 4): S206.
53. Salmon DP, Galasko D, Hansen LA, Masliah E, Butters N, Thal LJ, et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn 1996; 31: 148-65.
54. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer' and Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62: 243-52.
55. Ballard C, O'Brien J, Swann A, Neill D, Lantos P, Holmes C, et al. One year follow-up of parkinsonism in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2000; 11: 219-22.
56. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Br Med J 1992; 305: 673-8.
57. Del Ser T, Munoz DG, Hachinski V. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology 1996; 46: 682-6.
58. Mega MS, Masterman DL, Benson DF, Vinters HV, Tomiyasu U, Craig AH, et al. Dementia with Lewy bodies. Reliability and validity of clinical and pathologic criteria. Neurology 1996; 47: 1403-9.
59. Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 1998; 55: 969-78.
60. Briel RC, McKeith IG, Barker WA, Hewitt Y, Perry RH, Ince PG, et al. EEG findings in dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999; 66: 401-3.
61. Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, et al. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology 1998; 51: 357-62.
62. Ishii K, Imamura T, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 1998; 51: 125-30.
63. Wilcock GK, Scott MI. Tacrine for senile dementia of Alzheimer's or Lewy body type. Lancet 1994; 344: 544.
64. McKeith I, Del Ser T, Anand R, Cicin-Sain A, Ferrara R, Spiegel R. Rivastigmine provides symptomatic benefit in dementia with Lewy bodies: findings from a placebo-controlled international multicenter study. Neurology 2000; 54 (Suppl 3): A450.